| | | | | | | | | | |
|
| |
|
| Dockets Entered On April
7, 2006
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 2006D-0044
|
| Guidance for Industry on Patient-Reported
Outcome Measures: Use in Medical Product
Development to Support Labeling Claims
|
|
|
|
|
| 2006P-0137
|
| Nutrient Content Claim for EPA and DHA omega-3 fatty acids
|
|
|
|
|
| 2006D-0044
|
| Guidance for Industry on Patient-Reported
Outcome Measures: Use in Medical Product
Development to Support Labeling Claims
|
|
|
|
|
| EC 1
|
| M. D. Anderson Cancer Center
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 2
|
| EMGO Institute, VU University Medical Center
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 3
|
| NIH
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 4
|
| Capitol Outcomes Research, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 5
|
| EORTC Data Center
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 6
|
| Eli Lilly and Company
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 7
|
| Stanford University
|
| Vol #:
|
| 1
|
|
|
|
|
| EC 8
|
| GlaxoSmithKline
|
| Vol #:
|
| 1
|
|
|
|
|
| 2006P-0137
|
| Nutrient Content Claim for EPA and DHA omega-3 fatty acids
|
|
|
|
|
| ACK 1
|
| FDA/CFSAN to Ocean Nutrition Canada, Ltd
|
| Vol #:
|
| 1
|
|
|
|
|
| ANS 1
|
| FDA/CFSAN to Latham & Watkins LLP
|
| Vol #:
|
| 1
|
|
|
|
|
| CP 1
|
| Ocean Nutrition Canada, Ltd
|
| Vol #:
|
| 1
|
|
|
|
|
| LET 1
|
| Latham & Watkins LLP
|
| Vol #:
|
| 1
|
|
